← Back to Clinical Trials
Recruiting NCT04607174

NCT04607174 Voluntary Activation During Isokinetic Contractions in Subjects with Neuromotor Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04607174
Status Recruiting
Phase
Sponsor Istituto Auxologico Italiano
Condition Multiple Sclerosis
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2020-10-07
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Pathologic group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2020-10-07 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Activation is the amount of voluntary recruitment of a muscle during voluntary contraction. Full activation implies the recruitment of all muscle fibres at their tetanic frequency. In healthy subjects, and even in sports performances, full activation may be rarely achieved despite a subjectively maximal effort. Highly decreased activation has been observed in patients affected by various orthopaedic and neurological disorders. In these subjects, paresis may be caused or aggravated by primitive impairments of the central nervous system and/or, by stimuli arising from peripheral damaged tissues that inhibit the corticospinal or the intraspinal recruitment of motoneurones ("arthrogenous muscle weakness"). There are numerous investigations in the literature on activation measured during isometric contractions, while they are substantially missing as far as isokinetic concentric contractions are concerned. There are reasons to suppose that, contrary to what has been demonstrated for healthy subjects, in patients with various motor impairments the activation is diminished the more, the higher is the joint rotation speed. The present study aims to investigate the amount of activation of the quadriceps femoris during subjectively maximal isometric contractions at 40° knee flexion (0°=complete extension) and isokinetic concentric contractions at an angular velocity of 100°/s in patients with various orthopaedic and neurologic conditions. Activation will be measured on an isokinetic dynamometer, through the "interpolated twitch technique". This consists of stimulating a representative sample of the muscle belly through an electric shock. If the shock does not generate an extra force during contraction, all muscle fibres belonging to the sample reached by the electric shock can be claimed to be recruited at their tetanic frequency. Otherwise, following the stimulus, a twitch can be observed revealing submaximal voluntary recruitment of the muscle.

Eligibility Criteria

Inclusion Criteria: * age between 18 and 70 years old; * ability to sign the informed consent form; * ability to understand the instructions and to complete the motor task; * voluntary knee flexion-extension range of at least 70°; * maximal extension of angle \< 30° (0°=full extension, 180° sagittal tibio-femural angle). Exclusion Criteria: * pregnancy; * a history of epilepsy (to avoid the risk for seizures triggered by the stimuli); * Mini Mental State Examination ≤27/30; * implanted electro-sensitive devices; * any orthopedic condition limiting the articular mobility or muscular strength of the lower limbs; * current treatment with oral anticoagulant therapy (to avoid the risk for muscle hemorrhage); * medium/serius osteoporosis (femoral Bone Mineral Density on the affected side, t-score \< (-3.5)); * familiarity with the testing method.

Contact & Investigator

Central Contact

Luigi Tesio, MD, Full Professor

✉ l.tesio@auxologico.it

📞 02 58218717

Principal Investigator

Luigi Tesio, MD, Full professor

PRINCIPAL INVESTIGATOR

Istituto Auxologico Italiano

Frequently Asked Questions

Who can join the NCT04607174 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Multiple Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04607174 currently recruiting?

Yes, NCT04607174 is actively recruiting participants. Contact the research team at l.tesio@auxologico.it for enrollment information.

Where is the NCT04607174 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT04607174 clinical trial?

NCT04607174 is sponsored by Istituto Auxologico Italiano. The principal investigator is Luigi Tesio, MD, Full professor at Istituto Auxologico Italiano. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology